CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing lossTal Teitz, Jian Zuo|The Journal of Experimental Medicine|2018Cited by 102
Preclinical Models for Neuroblastoma: Establishing a Baseline for TreatmentTal Teitz, Jill M. Lahti|PLoS ONE|2011Cited by 97
Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing LossRichard D. Lutze, Tal Teitz|Pharmaceuticals|2024Cited by 3
Oseltamivir (Tamiflu), a Commonly Prescribed Antiviral Drug, Mitigates Hearing Loss in MiceEmma J. Sailor‐Longsworth, Tal Teitz|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1
FDA-Approved MEK1/2 Inhibitor, Trametinib, Protects Mice from Cisplatin and Noise-Induced Hearing LossRichard D. Lutze, Tal Teitz|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0